• New Drugs Approved
    • 2024 Approvals
    • 2023 Approvals
  • Health and Medical Research News
    • Arthritis
    • Bronchitis
    • Cancer
    • Diabetes
    • Eye
    • Heart Conditions
    • Vaccines and Infections
    • Mental Health
    • Neurology
    • Pain Conditions
    • Skin Conditions
    • Stomach & Intestine
FDA Approves Jaypirca for Mantle Cell Lymphoma Treatment on January 20, 2023

FDA Approves Jaypirca for Mantle Cell Lymphoma Treatment on January 20, 2023

by Jasmine C, B Jamerson | Jul 23, 2024 | 2023 Approvals, Drug approvals

What is Jaypirca prescribed for?   Jaypirca is prescribed to treat relapsed or refractory mantle cell lymphoma in adults who have had at least two lines of systemic therapy, including a BTK inhibitor.  What is the name of the drug and what does it do?...
Zurzuvae approved for treatment of postpartum depression on August 04, 2023

Zurzuvae approved for treatment of postpartum depression on August 04, 2023

by Jasmine C, B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals, New Drugs Approved

What is Zurzuvae prescribed for? Zurzuvae is prescribed to treat postpartum depression in adults.  What is the name of the drug and what does it do? Zurzuvae, pronounced ZUR-zoo-vay, (generic name: zuranolone) is a medication approved for treating postpartum...
Page 16 of 16« First«...1213141516

Latest Posts

  • Do All Men with Prostate Cancer Get the Same Treatment? A Look at Racial and Ethnic Gaps
  • New Light on Osteoarthritis: Innovative Imaging Techniques Unveil Early Joint Damage
  • New Combination Therapy Shows Promise for Advanced Urinary Tract Cancer
  • New Discovery Could Lead to Better Treatments for Rheumatoid Arthritis
  • Zepbound Injection Approved for Weight Loss in Overweight and Obese Adults on November 8, 2023

ScienceMyHealth is a product of iSimcha.

Navigate

HomePage

Blog

 

Company

About Us

Contact Us

© 2025 iSimcha

Privacy Policy

Terms of Service